http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19980702554-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04 |
| filingDate | 1995-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-19980702554-A |
| titleOfInvention | Use of isosorbide-5-monnitrate |
| abstract | The present invention provides a novel use of isosorbide-5-monnitrate for use in the manufacture of a medicament for the treatment of isolated cardiac contractile hypertension in humans or animals, and an effective amount of isosorbide-5-monitrate for A method for reducing seizure risk in patients with isolated cardiac contractile hypertension, comprising administering, is described. |
| priorityDate | 1995-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.